Legal Representation
Attorney
Jason DeFrancesco
USPTO Deadlines
Next Deadline
1941 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20250415)
Due Date
April 15, 2031
Grace Period Ends
October 15, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 22, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Oct 31, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Oct 31, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Oct 10, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Sep 24, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Sep 24, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Jul 16, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Apr 15, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 15, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 25, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 25, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 19, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 3, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 19, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 19, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 19, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 25, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Aug 5, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Aug 5, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jul 16, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jul 15, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 11, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 20, 2024 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| May 9, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| May 9, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 25, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 040
Processing services for active pharmaceutical ingredients and pharmaceutical intermediates, namely, custom manufacture of pharmaceuticals; custom manufacture of pharmaceutical products to order and in accordance with a customer's requirements; manufacturing of bio-pharmaceutical materials for others; treatment of bio-pharmaceutical materials by means of particle size engineering processings; microencapsulation services for third parties, namely, chemical encapsulation and dispersion of hazardous chemicals
Class 042
Providing medical and scientific research information in the field of pharmaceutical products; pharmaceutical research and development; medicine discovery services, namely research and development of medicines; pharmaceutical research and development services; technical and scientific advice relating to pharmacology; technical and scientific advice relating to pharmaceutical research; research and development of pharmaceutical products and medicines; inspection of pharmaceutical products for quality control; technical and scientific laboratory research in the field of pharmaceutical products; research in the field of pharmaceutical products; scientific research in the pharmaceutical field; pharmacological research services; medical and pharmacological research services; services for assessing the efficiency of pharmaceutical products, namely testing of pharmaceuticals; drug development for pharmaceutical use; development of pharmaceutical products; conducting preliminary evaluations in the field of new pharmaceutical products, namely, testing of pharmaceuticals; testing of pharmaceutical products; evaluation of the quality of pharmaceutical products; quality evaluation of chemical syntheses in the field of pharmaceuticals; technical consultancy services in the field of pharmaceuticals products
Class 044
Consultant services relating to pharmaceutical and medical products, namely, medical and pharmaceutical consultation; provision of information in the pharmaceutical field relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; consultant and information services relating to biopharmaceutical products, namely, pharmaceutical consultations; consultant and information services relating to pharmaceutical products, namely, pharmaceutical consultation; consultancy services relating to pharmaceutical products; pharmaceutical advice; dispensing of pharmaceutical products
Additional Information
Design Mark
The mark consists of the stylized letters "JP" within a circle comprised of smaller shaded circles.
Pseudo Mark
JET PHARMA
Classification
International Classes
040
042
044